{"Title": ["Biotech Stocks Facing FDA Decision In July 2020", "Eagle Pharmaceuticals Inc (EGRX) Q1 2020 Earnings Call Transcript", "Health Care Sector Update for 05/04/2020: EGRX,VIR,RARE,TEVA,BIIB", "BUZZ-U.S. STOCKS ON THE MOVE-Roku, Rite Aid, Jack in the Box, ThermoGenesis", "BUZZ-U.S. STOCKS ON THE MOVE-Edison Nation, Soligenix, Arcus Biosciences, Bed Bath & Beyond", "Health Care Sector Update for 03/17/2020: EGRX,BNTX,BAX,DBVT", "Validea's Top Five Healthcare Stocks Based On Kenneth Fisher - 3/15/2020", "Validea Peter Lynch Strategy Daily Upgrade Report - 3/10/2020", "Biotech Stocks Facing FDA Decision In July 2020", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 2/16/2020", "Eagle Pharmaceuticals Inc (EGRX) Q3 2019 Earnings Call Transcript", "Healthcare Stocks That Hit New Highs(RETA, KOD, NTRA\u2026)", "Eagle Pharmaceuticals Inc (EGRX) Q2 2019 Earnings Call Transcript", "Eagle Pharmaceuticals Inc (EGRX) Q1 2019 Earnings Call Transcript", "Eagle Pharmaceuticals Inc (EGRX) Q4 2018 Earnings Conference Call Transcript", "Analysts Estimate Eagle Pharmaceuticals (EGRX) to Report a Decline in Earnings: What to Look Out for", "Eagle Pharmaceuticals Inc (EGRX) Q4 2019 Earnings Call Transcript", "Should Value Investors Buy Eagle Pharmaceuticals (EGRX) Stock?", "Moving Average Crossover Alert: Eagle Pharmaceuticals (EGRX)", "After Hours Most Active for Oct 30, 2018 : PX, FB, QQQ, FDC, XOG, MS, F, PFE, MFGP, ERIC, EGRX, EBAY", "Commit To Buy Eagle Pharmaceuticals At $50, Earn 12.9% Annualized Using Options", "Baxter's Actifuse Flow Bone Graft Substitute Gets FDA Nod", "Agios (AGIO) Assigns Ex-Celgene Executive to CEO Position", "Emergent (EBS) Q2 Earnings and Revenues Surpass Estimates", "Earnings Preview: Eagle Pharmaceuticals (EGRX) Q4 Earnings Expected to Decline", "Should Value Investors Buy Eagle Pharmaceuticals (EGRX) Stock?", "Moving Average Crossover Alert: Eagle Pharmaceuticals (EGRX)", "After Hours Most Active for Oct 30, 2018 : PX, FB, QQQ, FDC, XOG, MS, F, PFE, MFGP, ERIC, EGRX, EBAY", "Commit To Purchase Eagle Pharmaceuticals At $65, Earn 9.3% Annualized Using Options", "Agios (AGIO) Secures FDA Approval for Leukemia Drug Tibsovo", "Health Care Sector Update for 05/16/2018: FOLD,SGMO,SNY,EGRX", "Health Care Sector Update for 05/16/2018: SGMO,SNY,EGRX", "Pacira (PCRX) Q2 Earnings and Revenues Surpass Estimates", "Acorda (ACOR) Q2 Earnings and Revenues Surpass Estimates", "Agios (AGIO) Q2 Loss Narrows, Revenues Surpass Estimates", "Conatus' (CNAT) Q2 Loss Narrows, Revenues Lag Marginally", "Commit To Purchase Eagle Pharmaceuticals At $65, Earn 9.3% Annualized Using Options", "Agios (AGIO) Secures FDA Approval for Leukemia Drug Tibsovo", "Health Care Sector Update for 05/16/2018: FOLD,SGMO,SNY,EGRX", "Health Care Sector Update for 05/16/2018: SGMO,SNY,EGRX", "Pacira (PCRX) Q2 Earnings and Revenues Surpass Estimates", "Acorda (ACOR) Q2 Earnings and Revenues Surpass Estimates", "Agios (AGIO) Q2 Loss Narrows, Revenues Surpass Estimates", "Conatus' (CNAT) Q2 Loss Narrows, Revenues Lag Marginally", "Commit To Purchase Eagle Pharmaceuticals At $65, Earn 9.3% Annualized Using Options", "Agios (AGIO) Secures FDA Approval for Leukemia Drug Tibsovo", "Health Care Sector Update for 05/16/2018: FOLD,SGMO,SNY,EGRX", "Health Care Sector Update for 05/16/2018: SGMO,SNY,EGRX", "Pacira (PCRX) Q2 Earnings and Revenues Surpass Estimates", "Health Care Sector Update for 05/10/2018: VRX,VRX.TO,EGRX,ARMO,LLY,QHC", "Health Care Sector Update for 05/10/2018: EGRX,ARMO,LLY,QHC", "Analysts Forecast 12% Gains Ahead For The Holdings of VIOG", "New Strong Sell Stocks for May 2nd", "Health Care Sector Update for 04/18/2018: ABT, FCSC, ENDP, SLDB", "Health Care Sector Update for 04/18/2018: SLDB,FCSC,ABT,ENDP,EGRX", "Health Care Sector Update for 04/18/2018: FCSC,ABT,ENDP,EGRX", "Health Care Sector Update for 05/10/2018: ARMO, LLY, VRX, MNOV, EGRX", "Health Care Sector Update for 05/10/2018: VRX,VRX.TO,EGRX,ARMO,LLY,QHC", "Health Care Sector Update for 05/10/2018: EGRX,ARMO,LLY,QHC", "Analysts Forecast 12% Gains Ahead For The Holdings of VIOG", "New Strong Sell Stocks for May 2nd", "Health Care Sector Update for 04/18/2018: ABT, FCSC, ENDP, SLDB", "Health Care Sector Update for 04/18/2018: SLDB,FCSC,ABT,ENDP,EGRX", "Health Care Sector Update for 04/18/2018: FCSC,ABT,ENDP,EGRX", "Health Care Sector Update for 05/10/2018: ARMO, LLY, VRX, MNOV, EGRX", "Eagle Pharmaceuticals (EGRX) Q4 2017 Earnings Conference Call Transcript", "Health Care Sector Update for 02/26/2018: ACHN, OBSV, EGRX, LLY, CNC", "Health Care Sector Update for 02/26/2018: PKI,EGRX,ACHN,CNC", "Health Care Sector Update for 02/26/2018: EGRX,ACHN,CNC", "Pre-Market Earnings Report for February 26, 2018 : CPRT, AWI, WBT, DORM, KOS, SEMG, BCC, GOV, NSA, EGRX, CLDT, DF", "Commit To Buy Eagle Pharmaceuticals At $60, Earn 27.3% Annualized Using Options", "First Eagle Fund of America Comments on Eagle Pharmaceuticals", "New Strong Sell Stocks for March 1st", "Monday 8/14 Insider Buying Report: EGRX, HPP", "Validea Joel Greenblatt Strategy Daily Upgrade Report", "Health Care Sector Update for 07/26/2017: EGRX,ARGS,USNA", "3 Stocks the Smartest Investors Are Buying Right Now", "Key FDA Events to Watch Out for in Jul 2017", "These 3 Stocks Are Up Over 500% in the Last 3 Years", "Eagle Pharmaceuticals (EGRX) Shares Cross Above 200 DMA", "Eagle Pharmaceuticals is Now Oversold", "Eagle Pharmaceuticals (EGRX) Shares Cross Below 200 DMA", "Health Care Sector Update for 05/15/2017: PTHN,CBMG,EGRX", "Health Care Sector Update for 05/15/2017: IONS, EGRX, CBMG", "Commit To Buy Eagle Pharmaceuticals At $75, Earn 11.3% Annualized Using Options", "7 Healthcare Stocks With A-Rated Prospects", "7 \u2018Best of the Best\u2019 Stocks to Buy for the Second Quarter", "3 Top Biotech Stocks to Buy in 2017", "Thursday 3/23 Insider Buying Report: PJT, EGRX", "Financial Sector Update for 08/23/2016: CCI,CHFC,CSH,EGRX", "Financial Sector Update for 08/23/2016: BMO,BMO.TO,CHFC,SVU,CSH,EGRX", "Eagle Pharmaceuticals (EGRX) Soars: Stock Moves 14.6% Higher", "Medical Product Stocks' Earnings on Aug 9: PEN, STE & More", "New Strong Sell Stocks for July 22nd", "Add Up The Parts: XBI Could Be Worth $80", "Why Energy Transfer Equity, Eagle Pharmaceuticals, and VirnetX Slumped Today", "Why Eagle Pharmaceuticals Inc. Flew 38.5% Higher in August", "Health Care Sector Update for 06/20/2016: TBPH,LPTN,EGRX", "Health Care Sector Update for 06/20/2016: FATE,LPTN,EGRX", "Teva Pharmaceutical Industries Ltd (ADR): TEVA Is Looking for Growth In All the Right Places", "Close Update: Nervous Investors Dump Equities For Safe-Haven of Government Bonds", "Why Eagle Pharmaceuticals, Inc. Skyrocketed 27.8% Today", "Even the Best Growth Stocks Can Quickly Become Losers", "Monday's ETF Movers: XBI, XME", "Why Cypress Semiconductor Corporation (CY), Eagle Pharmaceuticals Inc (EGRX) and Energy Transfer Equity LP (ETE) Are 3 of Today\u2019s Worst Stocks", "Health Care Sector Update for 05/09/2016: VBIV,VAC.TO,EGRX,UNIS", "Health Care Sector Update for 05/09/2016: HZNP,DEPO,EGRX,UNIS", "Noteworthy Wednesday Option Activity: EGRX, CBS, LORL", "What Makes Eagle Pharmaceuticals (EGRX) a Strong Sell?", "After Hours Most Active for Apr 5, 2016 : S, EPE, RAD, WPX, DNR, VNQI, PFE, CSCO, EGRX, BRCD, AVGO, SPLS", "Eagle Pharmaceuticals Down on CRL for Kangio from FDA", "Health Care Sector Update for 03/18/2016: EGRX,TBIO,HTBX", "Monday Sector Leaders: Drugs, Biotechnology Stocks", "Moving Average Crossover Alert: Eagle Pharmaceuticals (EGRX)", "Eagle Pharmaceuticals Enters Oversold Territory (EGRX)", "Commit To Purchase Eagle Pharmaceuticals At $55, Earn 20.3% Annualized Using Options", "Best Small-Cap Stocks of 2015", "The Zacks Analyst Blog Highlights: Eagle Pharmaceuticals, Recro Pharma, Amazon.com, Energy Focus and NVIDIA", "Waters Secures Regulatory Approvals for LC-MS Products", "The Zacks Analyst Blog Highlights: Dyax, Eagle Pharmaceuticals, Globant, Smith & Wesson Holding and Activision Blizzard", "Here's Why Eagle Pharmaceuticals' Stock Cratered Today", "Moving Average Crossover Alert: Eagle Pharmaceuticals (EGRX)", "5 Best-Performing Russell 2000 Stocks of 2015", "The Best Biotech Stocks in 2015", "Eagle's (EGRX) Non-Alcoholic Docetaxel Gets FDA Approval", "Health Care Sector Update for 12/24/2015: JNJ, PFE, ABT, MRK, AMGN, CLBS, EGRX, GWPH", "Earnings Estimates Moving Higher for Eagle Pharmaceuticals (EGRX): Time to Buy?", "3 Medtech Stocks that Doubled in 2015: Will the Trend Continue?", "Commit To Buy Eagle Pharmaceuticals At $65, Earn 24.1% Annualized Using Options", "Pre-Market Earnings Report for November 11, 2015 : M, GIB, ADT, CAE, PAH, NAT, EGRX, MTOR, STKL, NDRM, ELOS, INNL", "Health Care Sector Update for 09/29/2015: EGRX, ESPR, GTXI", "Pre-Market Earnings Report for August 11, 2015 : AER, TW, ZBRA, ACM, ARES, EGRX, RRGB, ARCO, RNF, MTLS, JASO, MGIC", "Why Eagle Pharmaceuticals (EGRX) Stock Might be a Great Pick - Tale of the Tape", "Will Medtronic Gain from the RF Surgical Systems Buyout? - Analyst Blog", "Weekly CEO Sells Highlight: ServiceNow Inc, Eagle Pharmaceuticals Inc, Avago Technologies Ltd, ...", "Eagle Pharmaceuticals (EGRX) Shares March Higher, Can It Continue?", "3 Moneymaking Biotech Stocks to Consider Buying", "5 Stocks Leading XBI Biotech ETF Higher - ETF News And Commentary", "How High Can Eagle Pharmaceuticals Fly On Teva Deal?", "3 Surprising Biotech Stocks That Are Surging Higher", "Pre-Market Earnings Report for May 12, 2015 : ECA, IFF, PAH, ACM, LDOS, IOC, ARES, ATRO, SWAY, EGRX, ARCO, IBP", "Will Eagle Pharmaceuticals (EGRX) Continue to Surge Higher? - Tale of the Tape", "Monday's ETF Movers: XBI, GXC", "Health Care Sector Update for 04/14/2015: TEVA, ICPI, SNY", "Eagle Pharmaceuticals (EGRX) in Focus: Stock Surges 10.9% - Tale of the Tape", "5 Stocks With Jaw-Dropping Growth Potential", "Health Care Sector Update for 02/18/2015: EGRX, CAPN, MDAS, TEVA", "Teva to Commercialize Eagle's Cancer Drug in the U.S. - Analyst Blog", "Why Shares of Eagle Pharmaceuticals Inc. Ripped Higher", "Health Care Sector Update for 02/17/2015: EGRX,TEVA,ONCY,CLTX", "3 Top Healthcare Stocks Surging Higher This Year", "Eagle Pharmaceuticals (EGRX) Jumps: Stock Gains 8.2% - Tale of the Tape", "Chimerix, Inc. (CMRX) in Focus: Stock Up 5.6% - Tale of the Tape", "Strength Seen in CareFusion (CFN): Stock Soars 22.9% - Tale of the Tape", "Rockwell Medical (RMTI) Jumps: Stock Gains 15.8% - Tale of the Tape", "Neogen Beats Q1 Earnings by a Penny; Revenues Miss - Analyst Blog", "Mead Johnson Unveils Production-R&D Center in Singapore - Analyst Blog", "Owens & Minor to Acquire ArcRoyal in Ireland; Shares Fall - Analyst Blog", "Eagle Pharmaceuticals (EGRX) Falls: Stock Goes Down 5.2% - Tale of the Tape", "Eagle Pharmaceuticals (EGRX) Jumps: Stock Gains 8.2% - Tale of the Tape", "Chimerix, Inc. (CMRX) in Focus: Stock Up 5.6% - Tale of the Tape", "Strength Seen in CareFusion (CFN): Stock Soars 22.9% - Tale of the Tape", "Rockwell Medical (RMTI) Jumps: Stock Gains 15.8% - Tale of the Tape", "St. Jude Medical Reports Positive 12-Month EnligHTN Data - Analyst Blog", "Rockwell Medical (RMTI) Jumps: Stock Moves 8.3% Higher - Tale of the Tape", "ZELTIQ Aesthetics (ZLTQ) Shows Strength: Stock Rises 8.8% - Tale of the Tape", "Boston Scientific Initiates REPRISE III Clinical Trial - Analyst Blog", "Is Abaxis (ABAX) a Buy After Solid Q2 Earnings? - Analyst Blog", "CareFusion Hits a New 52-Week High on Strong Q4 Results - Analyst Blog", "Insys Therapeutics' Cannabidiol Gets Orphan Drug Status - Analyst Blog", "Eagle Pharmaceuticals (EGRX) in Focus: Stock Moves 5.6% Higher - Tale of the Tape", "Why Unilife (UNIS) Could Be Positioned for a Slump - Tale of the Tape", "Boston Scientific's Vercise System Has Therapeutic Edge - Analyst Blog", "athenahealth's Epocrates Leads Digital Health Market - Analyst Blog", "Cerus (CERS) in Focus: Stock Moves 5.9% Higher - Tale of the Tape", "Is Abaxis (ABAX) a Buy After Solid Q2 Earnings? - Analyst Blog", "CareFusion Hits a New 52-Week High on Strong Q4 Results - Analyst Blog", "Insys Therapeutics' Cannabidiol Gets Orphan Drug Status - Analyst Blog", "Eagle Pharmaceuticals (EGRX) in Focus: Stock Moves 5.6% Higher - Tale of the Tape", "Why Unilife (UNIS) Could Be Positioned for a Slump - Tale of the Tape", "Boston Scientific's Vercise System Has Therapeutic Edge - Analyst Blog", "athenahealth's Epocrates Leads Digital Health Market - Analyst Blog", "Cerus (CERS) in Focus: Stock Moves 5.9% Higher - Tale of the Tape", "Is Abaxis (ABAX) a Buy After Solid Q2 Earnings? - Analyst Blog", "CareFusion Hits a New 52-Week High on Strong Q4 Results - Analyst Blog", "Insys Therapeutics' Cannabidiol Gets Orphan Drug Status - Analyst Blog", "Eagle Pharmaceuticals (EGRX) in Focus: Stock Moves 5.6% Higher - Tale of the Tape", "Why Unilife (UNIS) Could Be Positioned for a Slump - Tale of the Tape", "Boston Scientific's Vercise System Has Therapeutic Edge - Analyst Blog", "athenahealth's Epocrates Leads Digital Health Market - Analyst Blog", "Cerus (CERS) in Focus: Stock Moves 5.9% Higher - Tale of the Tape", "Is Abaxis (ABAX) a Buy After Solid Q2 Earnings? - Analyst Blog", "CareFusion Hits a New 52-Week High on Strong Q4 Results - Analyst Blog", "Insys Therapeutics' Cannabidiol Gets Orphan Drug Status - Analyst Blog", "Eagle Pharmaceuticals (EGRX) in Focus: Stock Moves 5.6% Higher - Tale of the Tape", "Why Unilife (UNIS) Could Be Positioned for a Slump - Tale of the Tape", "Boston Scientific's Vercise System Has Therapeutic Edge - Analyst Blog", "athenahealth's Epocrates Leads Digital Health Market - Analyst Blog", "Cerus (CERS) in Focus: Stock Moves 5.9% Higher - Tale of the Tape", "Updated Research Report on Quality Systems - Analyst Blog", "Positive Data on Baxter's VIVIA HD System - Analyst Blog", "PerkinElmer Launches New Air Monitoring Service - Analyst Blog", "Cerner Enters UAE's Health Care Industry - Analyst Blog", "GW Pharmaceuticals (GWPH) Jumps: Stock Rises 6.2% - Tale of the Tape", "Weakness Seen in NanoString Technologies (NSTG): Stock Tumbles 8.1% - Tale of the Tape", "Ecolab Partners with Hill-Rom Holdings - Analyst Blog", "FDA Approves Covidien's Micro Catheter - Analyst Blog", "Omeros' Omidria Gets FDA Nod - Analyst Blog", "Sector Update: Healthcare", "Sector Update: Healthcare Shares Flat; Synta Pharmaceuticals Soars on Positive Results From Breast Cancer Treatment Study", "Eagle Pharmaceuticals prices IPO at $15, the midpoint of the range", "Baxter Gets 510(k) Clearance for Next-Gen Infusion Pump - Analyst Blog", "Sector Update: Healthcare Shares Mixed Pre-Market; Eagle Pharmaceuticals' Q1 Loss Greater Than Expected", "St. Jude Medical's PORTICO Trial Under Way - Analyst Blog"], "Elapsed Time": ["2 DAYS AGO", "MAY 11, 2020", "MAY 4, 2020", "APR 16, 2020", "APR 16, 2020", "MAR 17, 2020", "MAR 15, 2020", "MAR 10, 2020", "2 DAYS AGO", "FEB 16, 2020", "NOV 12, 2019", "OCT 16, 2019", "AUG 9, 2019", "MAY 7, 2019", "FEB 28, 2019", "FEB 21, 2019", "MAR 2, 2020", "FEB 14, 2019", "NOV 16, 2018", "OCT 30, 2018", "OCT 22, 2018", "SEP 7, 2018", "SEP 5, 2018", "AUG 6, 2018", "FEB 18, 2019", "FEB 14, 2019", "NOV 16, 2018", "AUG 2, 2018", "JUL 23, 2018", "JUL 23, 2018", "MAY 16, 2018", "MAY 16, 2018", "AUG 6, 2018", "AUG 3, 2018", "AUG 3, 2018", "AUG 2, 2018", "JUL 23, 2018", "JUL 23, 2018", "MAY 16, 2018", "MAY 16, 2018", "AUG 6, 2018", "AUG 3, 2018", "AUG 3, 2018", "AUG 2, 2018", "JUL 23, 2018", "JUL 23, 2018", "MAY 16, 2018", "MAY 16, 2018", "AUG 6, 2018", "MAY 10, 2018", "MAY 10, 2018", "MAY 4, 2018", "MAY 2, 2018", "APR 18, 2018", "APR 18, 2018", "APR 18, 2018", "MAY 10, 2018", "MAY 10, 2018", "MAY 10, 2018", "MAY 4, 2018", "MAY 2, 2018", "APR 18, 2018", "APR 18, 2018", "APR 18, 2018", "MAY 10, 2018", "FEB 27, 2018", "FEB 26, 2018", "FEB 26, 2018", "FEB 26, 2018", "FEB 23, 2018", "FEB 20, 2018", "OCT 31, 2017", "MAR 1, 2018", "AUG 14, 2017", "JUL 26, 2017", "JUL 26, 2017", "JUL 20, 2017", "JUL 3, 2017", "JUN 25, 2017", "JUN 19, 2017", "OCT 16, 2017", "MAY 25, 2017", "MAY 15, 2017", "MAY 15, 2017", "MAY 5, 2017", "APR 21, 2017", "MAR 31, 2017", "JAN 16, 2017", "MAR 23, 2017", "AUG 23, 2016", "AUG 23, 2016", "AUG 10, 2016", "AUG 8, 2016", "JUL 22, 2016", "JUN 28, 2016", "JUN 20, 2016", "SEP 9, 2016", "JUN 20, 2016", "JUN 20, 2016", "JUN 15, 2016", "JUN 10, 2016", "JUN 10, 2016", "JUN 10, 2016", "MAY 9, 2016", "JUN 20, 2016", "MAY 9, 2016", "MAY 9, 2016", "MAY 4, 2016", "APR 7, 2016", "APR 5, 2016", "MAR 21, 2016", "MAR 18, 2016", "MAY 9, 2016", "MAR 1, 2016", "JAN 27, 2016", "JAN 15, 2016", "JAN 12, 2016", "JAN 6, 2016", "JAN 6, 2016", "JAN 4, 2016", "MAR 18, 2016", "MAR 1, 2016", "DEC 29, 2015", "DEC 28, 2015", "DEC 28, 2015", "DEC 24, 2015", "DEC 16, 2015", "JAN 4, 2016", "NOV 18, 2015", "NOV 10, 2015", "SEP 29, 2015", "AUG 10, 2015", "JUL 16, 2015", "JUL 14, 2015", "JUL 11, 2015", "DEC 11, 2015", "JUL 5, 2015", "JUN 25, 2015", "JUN 17, 2015", "JUN 6, 2015", "MAY 11, 2015", "APR 22, 2015", "JUL 6, 2015", "APR 14, 2015", "APR 2, 2015", "FEB 28, 2015", "FEB 18, 2015", "FEB 18, 2015", "FEB 17, 2015", "FEB 17, 2015", "APR 18, 2015", "NOV 11, 2014", "OCT 8, 2014", "OCT 7, 2014", "OCT 6, 2014", "SEP 26, 2014", "SEP 25, 2014", "SEP 25, 2014", "JAN 13, 2015", "NOV 11, 2014", "OCT 8, 2014", "OCT 7, 2014", "OCT 6, 2014", "SEP 15, 2014", "SEP 12, 2014", "SEP 11, 2014", "SEP 24, 2014", "SEP 8, 2014", "SEP 5, 2014", "AUG 26, 2014", "JUL 1, 2014", "JUN 11, 2014", "JUN 11, 2014", "JUN 11, 2014", "SEP 10, 2014", "SEP 8, 2014", "SEP 5, 2014", "AUG 26, 2014", "JUL 1, 2014", "JUN 11, 2014", "JUN 11, 2014", "JUN 11, 2014", "SEP 10, 2014", "SEP 8, 2014", "SEP 5, 2014", "AUG 26, 2014", "JUL 1, 2014", "JUN 11, 2014", "JUN 11, 2014", "JUN 11, 2014", "SEP 10, 2014", "SEP 8, 2014", "SEP 5, 2014", "AUG 26, 2014", "JUL 1, 2014", "JUN 11, 2014", "JUN 11, 2014", "JUN 11, 2014", "SEP 10, 2014", "JUN 11, 2014", "JUN 10, 2014", "JUN 10, 2014", "JUN 10, 2014", "JUN 9, 2014", "JUN 9, 2014", "JUN 9, 2014", "JUN 11, 2014", "JUN 3, 2014", "MAR 20, 2014", "MAR 20, 2014", "FEB 12, 2014", "MAY 15, 2014", "MAY 14, 2014", "MAY 27, 2014"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-july-2020-2020-06-25", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-inc-egrx-q1-2020-earnings-call-transcript-2020-05-11", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-04-2020%3A-egrxvirraretevabiib-2020-05-04", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-roku-rite-aid-jack-in-the-box-thermogenesis-2020-04-16", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-edison-nation-soligenix-arcus-biosciences-bed-bath-beyond", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-17-2020%3A-egrxbntxbaxdbvt-2020-03-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-kenneth-fisher-3-15-2020-2020-03-15", "https://www.nasdaq.com/articles/validea-peter-lynch-strategy-daily-upgrade-report-3-10-2020-2020-03-10", "https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-july-2020-2020-06-25", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-peter-lynch-2-16-2020-2020-02-16", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-inc-egrx-q3-2019-earnings-call-transcript-2019-11-12", "https://www.nasdaq.com/articles/healthcare-stocks-that-hit-new-highsreta-kod-ntra...-2019-10-16", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-inc-egrx-q2-2019-earnings-call-transcript-2019-08-09", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-inc-egrx-q1-2019-earnings-call-transcript-2019-05-07", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-inc-egrx-q4-2018-earnings-conference-call-transcript-2019-02-28", "https://www.nasdaq.com/articles/analysts-estimate-eagle-pharmaceuticals-egrx-to-report-a-decline-in-earnings%3A-what-to-1", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-inc-egrx-q4-2019-earnings-call-transcript-2020-03-02", "https://www.nasdaq.com/articles/should-value-investors-buy-eagle-pharmaceuticals-egrx-stock-2019-02-14", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-eagle-pharmaceuticals-egrx-2018-11-16", "https://www.nasdaq.com/articles/after-hours-most-active-oct-30-2018-px-fb-qqq-fdc-xog-ms-f-pfe-mfgp-eric-egrx-ebay-2018-10", "https://www.nasdaq.com/articles/commit-buy-eagle-pharmaceuticals-50-earn-129-annualized-using-options-2018-10-22", "https://www.nasdaq.com/articles/baxters-actifuse-flow-bone-graft-substitute-gets-fda-nod-2018-09-07", "https://www.nasdaq.com/articles/agios-agio-assigns-ex-celgene-executive-to-ceo-position-2018-09-05", "https://www.nasdaq.com/articles/emergent-ebs-q2-earnings-and-revenues-surpass-estimates-2018-08-06", "https://www.nasdaq.com/articles/earnings-preview%3A-eagle-pharmaceuticals-egrx-q4-earnings-expected-to-decline-2019-02-18", "https://www.nasdaq.com/articles/should-value-investors-buy-eagle-pharmaceuticals-egrx-stock-2019-02-14", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-eagle-pharmaceuticals-egrx-2018-11-16", "https://www.nasdaq.com/articles/conatus-cnat-q2-loss-narrows-revenues-lag-marginally-2018-08-02", "https://www.nasdaq.com/articles/commit-purchase-eagle-pharmaceuticals-65-earn-93-annualized-using-options-2018-07-23", "https://www.nasdaq.com/articles/agios-agio-secures-fda-approval-for-leukemia-drug-tibsovo-2018-07-23", "https://www.nasdaq.com/articles/health-care-sector-update-05162018-foldsgmosnyegrx-2018-05-16", "https://www.nasdaq.com/articles/health-care-sector-update-05162018-sgmosnyegrx-2018-05-16", "https://www.nasdaq.com/articles/pacira-pcrx-q2-earnings-and-revenues-surpass-estimates-2018-08-06", "https://www.nasdaq.com/articles/acorda-acor-q2-earnings-and-revenues-surpass-estimates-2018-08-03", "https://www.nasdaq.com/articles/agios-agio-q2-loss-narrows-revenues-surpass-estimates-2018-08-03", "https://www.nasdaq.com/articles/conatus-cnat-q2-loss-narrows-revenues-lag-marginally-2018-08-02", "https://www.nasdaq.com/articles/commit-purchase-eagle-pharmaceuticals-65-earn-93-annualized-using-options-2018-07-23", "https://www.nasdaq.com/articles/agios-agio-secures-fda-approval-for-leukemia-drug-tibsovo-2018-07-23", "https://www.nasdaq.com/articles/health-care-sector-update-05162018-foldsgmosnyegrx-2018-05-16", "https://www.nasdaq.com/articles/health-care-sector-update-05162018-sgmosnyegrx-2018-05-16", "https://www.nasdaq.com/articles/pacira-pcrx-q2-earnings-and-revenues-surpass-estimates-2018-08-06", "https://www.nasdaq.com/articles/acorda-acor-q2-earnings-and-revenues-surpass-estimates-2018-08-03", "https://www.nasdaq.com/articles/agios-agio-q2-loss-narrows-revenues-surpass-estimates-2018-08-03", "https://www.nasdaq.com/articles/conatus-cnat-q2-loss-narrows-revenues-lag-marginally-2018-08-02", "https://www.nasdaq.com/articles/commit-purchase-eagle-pharmaceuticals-65-earn-93-annualized-using-options-2018-07-23", "https://www.nasdaq.com/articles/agios-agio-secures-fda-approval-for-leukemia-drug-tibsovo-2018-07-23", "https://www.nasdaq.com/articles/health-care-sector-update-05162018-foldsgmosnyegrx-2018-05-16", "https://www.nasdaq.com/articles/health-care-sector-update-05162018-sgmosnyegrx-2018-05-16", "https://www.nasdaq.com/articles/health-care-sector-update-05102018-armo-lly-vrx-mnov-egrx-2018-05-10", "https://www.nasdaq.com/articles/health-care-sector-update-05102018-vrxvrxtoegrxarmollyqhc-2018-05-10", "https://www.nasdaq.com/articles/health-care-sector-update-05102018-egrxarmollyqhc-2018-05-10", "https://www.nasdaq.com/articles/analysts-forecast-12-gains-ahead-holdings-viog-2018-05-04", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-may-2nd-2018-05-02", "https://www.nasdaq.com/articles/health-care-sector-update-04182018-abt-fcsc-endp-sldb-2018-04-18", "https://www.nasdaq.com/articles/health-care-sector-update-04182018-sldbfcscabtendpegrx-2018-04-18", "https://www.nasdaq.com/articles/health-care-sector-update-04182018-fcscabtendpegrx-2018-04-18", "https://www.nasdaq.com/articles/health-care-sector-update-05102018-armo-lly-vrx-mnov-egrx-2018-05-10", "https://www.nasdaq.com/articles/health-care-sector-update-05102018-vrxvrxtoegrxarmollyqhc-2018-05-10", "https://www.nasdaq.com/articles/health-care-sector-update-05102018-egrxarmollyqhc-2018-05-10", "https://www.nasdaq.com/articles/analysts-forecast-12-gains-ahead-holdings-viog-2018-05-04", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-may-2nd-2018-05-02", "https://www.nasdaq.com/articles/health-care-sector-update-04182018-abt-fcsc-endp-sldb-2018-04-18", "https://www.nasdaq.com/articles/health-care-sector-update-04182018-sldbfcscabtendpegrx-2018-04-18", "https://www.nasdaq.com/articles/health-care-sector-update-04182018-fcscabtendpegrx-2018-04-18", "https://www.nasdaq.com/articles/health-care-sector-update-05102018-armo-lly-vrx-mnov-egrx-2018-05-10", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-q4-2017-earnings-conference-call-transcript-2018-02-27", "https://www.nasdaq.com/articles/health-care-sector-update-02262018-achn-obsv-egrx-lly-cnc-2018-02-26", "https://www.nasdaq.com/articles/health-care-sector-update-02262018-pkiegrxachncnc-2018-02-26", "https://www.nasdaq.com/articles/health-care-sector-update-02262018-egrxachncnc-2018-02-26", "https://www.nasdaq.com/articles/pre-market-earnings-report-february-26-2018-cprt-awi-wbt-dorm-kos-semg-bcc-gov-nsa-egrx", "https://www.nasdaq.com/articles/commit-buy-eagle-pharmaceuticals-60-earn-273-annualized-using-options-2018-02-20", "https://www.nasdaq.com/articles/first-eagle-fund-america-comments-eagle-pharmaceuticals-2017-10-31", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-march-1st-2018-03-01", "https://www.nasdaq.com/articles/monday-814-insider-buying-report-egrx-hpp-2017-08-14", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-2017-07-26", "https://www.nasdaq.com/articles/health-care-sector-update-07262017-egrxargsusna-2017-07-26", "https://www.nasdaq.com/articles/3-stocks-smartest-investors-are-buying-right-now-2017-07-20", "https://www.nasdaq.com/articles/key-fda-events-watch-out-jul-2017-2017-07-03", "https://www.nasdaq.com/articles/these-3-stocks-are-over-500-last-3-years-2017-06-25", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-shares-cross-above-200-dma-2017-06-19", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-now-oversold-2017-10-16", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-shares-cross-below-200-dma-2017-05-25", "https://www.nasdaq.com/articles/health-care-sector-update-05152017-pthncbmgegrx-2017-05-15", "https://www.nasdaq.com/articles/health-care-sector-update-05152017-ions-egrx-cbmg-2017-05-15", "https://www.nasdaq.com/articles/commit-buy-eagle-pharmaceuticals-75-earn-113-annualized-using-options-2017-05-05", "https://www.nasdaq.com/articles/7-healthcare-stocks-with-a-rated-prospects-2017-04-21", "https://www.nasdaq.com/articles/7-best-of-the-best-stocks-to-buy-for-the-second-quarter-2017-03-31", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-january-16th-2017-01-16", "https://www.nasdaq.com/articles/thursday-323-insider-buying-report-pjt-egrx-2017-03-23", "https://www.nasdaq.com/articles/financial-sector-update-08232016-ccichfccshegrx-2016-08-23", "https://www.nasdaq.com/articles/financial-sector-update-08232016-bmobmotochfcsvucshegrx-2016-08-23", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-soars%3A-stock-moves-14.6-higher-2016-08-10", "https://www.nasdaq.com/articles/medical-product-stocks-earnings-on-aug-9%3A-pen-ste-more-2016-08-08", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-july-22nd-2016-07-22", "https://www.nasdaq.com/articles/add-parts-xbi-could-be-worth-80-2016-06-28", "https://www.nasdaq.com/articles/why-energy-transfer-equity-eagle-pharmaceuticals-and-virnetx-slumped-today-2016-06-20", "https://www.nasdaq.com/articles/why-eagle-pharmaceuticals-inc-flew-385-higher-august-2016-09-09", "https://www.nasdaq.com/articles/health-care-sector-update-06202016-tbphlptnegrx-2016-06-20", "https://www.nasdaq.com/articles/health-care-sector-update-06202016-fatelptnegrx-2016-06-20", "https://www.nasdaq.com/articles/teva-pharmaceutical-industries-ltd-adr%3A-teva-is-looking-for-growth-in-all-the-right-places", "https://www.nasdaq.com/articles/close-update-nervous-investors-dump-equities-safe-haven-government-bonds-2016-06-10", "https://www.nasdaq.com/articles/why-eagle-pharmaceuticals-inc-skyrocketed-278-today-2016-06-10", "https://www.nasdaq.com/articles/even-best-growth-stocks-can-quickly-become-losers-2016-06-10", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-xme-2016-05-09", "https://www.nasdaq.com/articles/why-cypress-semiconductor-corporation-cy-eagle-pharmaceuticals-inc-egrx-and-energy", "https://www.nasdaq.com/articles/health-care-sector-update-05092016-vbivvactoegrxunis-2016-05-09", "https://www.nasdaq.com/articles/health-care-sector-update-05092016-hznpdepoegrxunis-2016-05-09", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-egrx-cbs-lorl-2016-05-04", "https://www.nasdaq.com/articles/what-makes-eagle-pharmaceuticals-egrx-a-strong-sell-2016-04-07", "https://www.nasdaq.com/articles/after-hours-most-active-apr-5-2016-s-epe-rad-wpx-dnr-vnqi-pfe-csco-egrx-brcd-avgo-spls", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-down-on-crl-for-kangio-from-fda-2016-03-21", "https://www.nasdaq.com/articles/health-care-sector-update-03182016-egrxtbiohtbx-2016-03-18", "https://www.nasdaq.com/articles/monday-sector-leaders-drugs-biotechnology-stocks-2016-05-09", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-eagle-pharmaceuticals-egrx-2016-03-01", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-enters-oversold-territory-egrx-2016-01-27", "https://www.nasdaq.com/articles/commit-purchase-eagle-pharmaceuticals-55-earn-203-annualized-using-options-2016-01-15", "https://www.nasdaq.com/articles/best-small-cap-stocks-2015-2016-01-12", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-eagle-pharmaceuticals-recro-pharma-amazon.com-energy", "https://www.nasdaq.com/articles/waters-secures-regulatory-approvals-for-lc-ms-products-2016-01-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-dyax-eagle-pharmaceuticals-globant-smith-wesson-holding", "https://www.nasdaq.com/articles/heres-why-eagle-pharmaceuticals-stock-cratered-today-2016-03-18", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-eagle-pharmaceuticals-egrx-2016-03-01", "https://www.nasdaq.com/articles/5-best-performing-russell-2000-stocks-of-2015-2015-12-29", "https://www.nasdaq.com/articles/best-biotech-stocks-2015-2015-12-28", "https://www.nasdaq.com/articles/eagles-egrx-non-alcoholic-docetaxel-gets-fda-approval-2015-12-28", "https://www.nasdaq.com/articles/health-care-sector-update-12242015-jnj-pfe-abt-mrk-amgn-clbs-egrx-gwph-2015-12-24", "https://www.nasdaq.com/articles/earnings-estimates-moving-higher-for-eagle-pharmaceuticals-egrx%3A-time-to-buy-2015-12-16", "https://www.nasdaq.com/articles/3-medtech-stocks-that-doubled-in-2015%3A-will-the-trend-continue-2016-01-04", "https://www.nasdaq.com/articles/commit-buy-eagle-pharmaceuticals-65-earn-241-annualized-using-options-2015-11-18", "https://www.nasdaq.com/articles/pre-market-earnings-report-november-11-2015-m-gib-adt-cae-pah-nat-egrx-mtor-stkl-ndrm-elos", "https://www.nasdaq.com/articles/health-care-sector-update-09292015-egrx-espr-gtxi-2015-09-29", "https://www.nasdaq.com/articles/pre-market-earnings-report-august-11-2015-aer-tw-zbra-acm-ares-egrx-rrgb-arco-rnf-mtls", "https://www.nasdaq.com/articles/why-eagle-pharmaceuticals-egrx-stock-might-be-a-great-pick-tale-of-the-tape-2015-07-16", "https://www.nasdaq.com/articles/will-medtronic-gain-from-the-rf-surgical-systems-buyout-analyst-blog-2015-07-14", "https://www.nasdaq.com/articles/weekly-ceo-sells-highlight-servicenow-inc-eagle-pharmaceuticals-inc-avago-technologies-ltd", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-shares-march-higher-can-it-continue-2015-12-11", "https://www.nasdaq.com/articles/3-moneymaking-biotech-stocks-consider-buying-2015-07-05", "https://www.nasdaq.com/articles/5-stocks-leading-xbi-biotech-etf-higher-etf-news-and-commentary-2015-06-25", "https://www.nasdaq.com/articles/how-high-can-eagle-pharmaceuticals-fly-teva-deal-2015-06-17", "https://www.nasdaq.com/articles/3-surprising-biotech-stocks-are-surging-higher-2015-06-06", "https://www.nasdaq.com/articles/pre-market-earnings-report-may-12-2015-eca-iff-pah-acm-ldos-ioc-ares-atro-sway-egrx-arco", "https://www.nasdaq.com/articles/will-eagle-pharmaceuticals-egrx-continue-to-surge-higher-tale-of-the-tape-2015-04-22", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-gxc-2015-07-06", "https://www.nasdaq.com/articles/health-care-sector-update-04142015-teva-icpi-sny-2015-04-14", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-in-focus%3A-stock-surges-10.9-tale-of-the-tape-2015-04-02", "https://www.nasdaq.com/articles/5-stocks-jaw-dropping-growth-potential-2015-02-28", "https://www.nasdaq.com/articles/health-care-sector-update-02182015-egrx-capn-mdas-teva-2015-02-18", "https://www.nasdaq.com/articles/teva-to-commercialize-eagles-cancer-drug-in-the-u.s.-analyst-blog-2015-02-18", "https://www.nasdaq.com/articles/why-shares-eagle-pharmaceuticals-inc-ripped-higher-2015-02-17", "https://www.nasdaq.com/articles/health-care-sector-update-02172015-egrxtevaoncycltx-2015-02-17", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-surging-higher-year-2015-04-18", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-jumps%3A-stock-gains-8.2-tale-of-the-tape-2014-11-11", "https://www.nasdaq.com/articles/chimerix-inc.-cmrx-in-focus%3A-stock-up-5.6-tale-of-the-tape-2014-10-08", "https://www.nasdaq.com/articles/strength-seen-in-carefusion-cfn%3A-stock-soars-22.9-tale-of-the-tape-2014-10-07", "https://www.nasdaq.com/articles/rockwell-medical-rmti-jumps%3A-stock-gains-15.8-tale-of-the-tape-2014-10-06", "https://www.nasdaq.com/articles/neogen-beats-q1-earnings-by-a-penny-revenues-miss-analyst-blog-2014-09-26", "https://www.nasdaq.com/articles/mead-johnson-unveils-production-rd-center-in-singapore-analyst-blog-2014-09-25", "https://www.nasdaq.com/articles/owens-minor-to-acquire-arcroyal-in-ireland-shares-fall-analyst-blog-2014-09-25", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-falls%3A-stock-goes-down-5.2-tale-of-the-tape-2015-01-13", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-jumps%3A-stock-gains-8.2-tale-of-the-tape-2014-11-11", "https://www.nasdaq.com/articles/chimerix-inc.-cmrx-in-focus%3A-stock-up-5.6-tale-of-the-tape-2014-10-08", "https://www.nasdaq.com/articles/strength-seen-in-carefusion-cfn%3A-stock-soars-22.9-tale-of-the-tape-2014-10-07", "https://www.nasdaq.com/articles/rockwell-medical-rmti-jumps%3A-stock-gains-15.8-tale-of-the-tape-2014-10-06", "https://www.nasdaq.com/articles/st.-jude-medical-reports-positive-12-month-enlightn-data-analyst-blog-2014-09-15", "https://www.nasdaq.com/articles/rockwell-medical-rmti-jumps%3A-stock-moves-8.3-higher-tale-of-the-tape-2014-09-12", "https://www.nasdaq.com/articles/zeltiq-aesthetics-zltq-shows-strength%3A-stock-rises-8.8-tale-of-the-tape-2014-09-11", "https://www.nasdaq.com/articles/boston-scientific-initiates-reprise-iii-clinical-trial-analyst-blog-2014-09-24", "https://www.nasdaq.com/articles/is-abaxis-abax-a-buy-after-solid-q2-earnings-analyst-blog-2014-09-08", "https://www.nasdaq.com/articles/carefusion-hits-a-new-52-week-high-on-strong-q4-results-analyst-blog-2014-09-05", "https://www.nasdaq.com/articles/insys-therapeutics-cannabidiol-gets-orphan-drug-status-analyst-blog-2014-08-26", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-in-focus%3A-stock-moves-5.6-higher-tale-of-the-tape-2014-07-01", "https://www.nasdaq.com/articles/why-unilife-unis-could-be-positioned-for-a-slump-tale-of-the-tape-2014-06-11", "https://www.nasdaq.com/articles/boston-scientifics-vercise-system-has-therapeutic-edge-analyst-blog-2014-06-11", "https://www.nasdaq.com/articles/athenahealths-epocrates-leads-digital-health-market-analyst-blog-2014-06-11", "https://www.nasdaq.com/articles/cerus-cers-in-focus%3A-stock-moves-5.9-higher-tale-of-the-tape-2014-09-10", "https://www.nasdaq.com/articles/is-abaxis-abax-a-buy-after-solid-q2-earnings-analyst-blog-2014-09-08", "https://www.nasdaq.com/articles/carefusion-hits-a-new-52-week-high-on-strong-q4-results-analyst-blog-2014-09-05", "https://www.nasdaq.com/articles/insys-therapeutics-cannabidiol-gets-orphan-drug-status-analyst-blog-2014-08-26", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-in-focus%3A-stock-moves-5.6-higher-tale-of-the-tape-2014-07-01", "https://www.nasdaq.com/articles/why-unilife-unis-could-be-positioned-for-a-slump-tale-of-the-tape-2014-06-11", "https://www.nasdaq.com/articles/boston-scientifics-vercise-system-has-therapeutic-edge-analyst-blog-2014-06-11", "https://www.nasdaq.com/articles/athenahealths-epocrates-leads-digital-health-market-analyst-blog-2014-06-11", "https://www.nasdaq.com/articles/cerus-cers-in-focus%3A-stock-moves-5.9-higher-tale-of-the-tape-2014-09-10", "https://www.nasdaq.com/articles/is-abaxis-abax-a-buy-after-solid-q2-earnings-analyst-blog-2014-09-08", "https://www.nasdaq.com/articles/carefusion-hits-a-new-52-week-high-on-strong-q4-results-analyst-blog-2014-09-05", "https://www.nasdaq.com/articles/insys-therapeutics-cannabidiol-gets-orphan-drug-status-analyst-blog-2014-08-26", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-in-focus%3A-stock-moves-5.6-higher-tale-of-the-tape-2014-07-01", "https://www.nasdaq.com/articles/why-unilife-unis-could-be-positioned-for-a-slump-tale-of-the-tape-2014-06-11", "https://www.nasdaq.com/articles/boston-scientifics-vercise-system-has-therapeutic-edge-analyst-blog-2014-06-11", "https://www.nasdaq.com/articles/athenahealths-epocrates-leads-digital-health-market-analyst-blog-2014-06-11", "https://www.nasdaq.com/articles/cerus-cers-in-focus%3A-stock-moves-5.9-higher-tale-of-the-tape-2014-09-10", "https://www.nasdaq.com/articles/is-abaxis-abax-a-buy-after-solid-q2-earnings-analyst-blog-2014-09-08", "https://www.nasdaq.com/articles/carefusion-hits-a-new-52-week-high-on-strong-q4-results-analyst-blog-2014-09-05", "https://www.nasdaq.com/articles/insys-therapeutics-cannabidiol-gets-orphan-drug-status-analyst-blog-2014-08-26", "https://www.nasdaq.com/articles/eagle-pharmaceuticals-egrx-in-focus%3A-stock-moves-5.6-higher-tale-of-the-tape-2014-07-01", "https://www.nasdaq.com/articles/why-unilife-unis-could-be-positioned-for-a-slump-tale-of-the-tape-2014-06-11", "https://www.nasdaq.com/articles/boston-scientifics-vercise-system-has-therapeutic-edge-analyst-blog-2014-06-11", "https://www.nasdaq.com/articles/athenahealths-epocrates-leads-digital-health-market-analyst-blog-2014-06-11", "https://www.nasdaq.com/articles/cerus-cers-in-focus%3A-stock-moves-5.9-higher-tale-of-the-tape-2014-09-10", "https://www.nasdaq.com/articles/updated-research-report-on-quality-systems-analyst-blog-2014-06-11", "https://www.nasdaq.com/articles/positive-data-on-baxters-vivia-hd-system-analyst-blog-2014-06-10", "https://www.nasdaq.com/articles/perkinelmer-launches-new-air-monitoring-service-analyst-blog-2014-06-10", "https://www.nasdaq.com/articles/cerner-enters-uaes-health-care-industry-analyst-blog-2014-06-10", "https://www.nasdaq.com/articles/gw-pharmaceuticals-gwph-jumps%3A-stock-rises-6.2-tale-of-the-tape-2014-06-09", "https://www.nasdaq.com/articles/weakness-seen-in-nanostring-technologies-nstg%3A-stock-tumbles-8.1-tale-of-the-tape-2014-06", "https://www.nasdaq.com/articles/ecolab-partners-with-hill-rom-holdings-analyst-blog-2014-06-09", "https://www.nasdaq.com/articles/fda-approves-covidiens-micro-catheter-analyst-blog-2014-06-11", "https://www.nasdaq.com/articles/omeros-omidria-gets-fda-nod-analyst-blog-2014-06-03", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-03-20-1", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-synta-pharmaceuticals-soars-positive-results-breast", "https://www.nasdaq.com/articles/fda-lowers-risk-label-on-covidiens-pillcam-analyst-blog-2014-05-20", "https://www.nasdaq.com/articles/baxter-gets-510k-clearance-for-next-gen-infusion-pump-analyst-blog-2014-05-15", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixed-pre-market-eagle-pharmaceuticals-q1-loss-greater", "https://www.nasdaq.com/articles/st.-jude-medicals-portico-trial-under-way-analyst-blog-2014-05-27"], "Content": []}